Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

SMTI

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2022-11-08Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,457,486Shares Outstanding:8,706,678Institutional Ownership Pct.:16.74%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	15	14	17	15	17	21	16	16	6	3	5	6
Accounts Receivable Net Current	13	14	-	-	-	-	-	-	-	-	-	-
Inventory Net	3	3	4	3	4	3	3	3	4	4	5	5
Other Receivables Net Current	-	-	-	-	-	-	1	1	-	-	-	-
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	0	0	1	1	1
Assets Of Disposal Group Including Discontinued Op…	0	0	0	0	-	-	0	-	-	-	-	-
Assets Current	32	31	34	31	34	37	33	32	21	17	19	19
Assets Noncurrent
Intangible Assets Net Excluding Goodwill	17	18	19	21	41	42	23	42	43	44	45	46
Goodwill	4	4	4	4	4	4	4	4	4	4	4	4
Long Term Investments	14	14	15	13	11	11	6	8	3	3	3	3
Operating Lease Right Of Use Asset	2	2	2	2	1	1	1	2	2	2	2	2
Property Plant And Equipment Net	0	0	0	0	9	2	0	1	1	1	1	1
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	-	20	-	-	-	-	-
Assets Noncurrent	37	38	39	40	65	60	55	57	53	54	55	56
Assets	69	69	73	71	99	96	88	89	73	71	74	74
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	-	-	-	-	-	-	-	-	-	-	-
Accrued Sales Commission Current	7	9	12	11	10	8	10	8	7	7	8	6
Accrued Royalties Current	4	3	3	3	3	3	2	2	2	2	2	4
Other Liabilities Current	-	-	0	0	0	-	-	2	1	1	1	1
Long Term Debt Current	-	-	-	-	-	-	-	-	-	1	1	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Of Disposal Group Including Discontinu…	0	1	1	2	-	-	1	-	-	-	-	-
Liabilities Current	12	14	19	17	15	13	15	14	12	13	14	13
Liabilities Noncurrent
Long Term Debt Noncurrent	46	46	46	45	44	43	31	30	14	9	9	9
Other Liabilities Noncurrent	-	-	-	-	2	1	1	2	3	3	3	5
Operating Lease Liability Noncurrent	2	2	2	2	1	1	1	1	2	2	2	2
Other Long Term Debt	1	1	1	1	1	1	1	1	2	2	2	2
Liabilities Noncurrent	49	49	48	48	48	46	34	35	20	15	16	18
Liabilities	61	62	67	65	63	60	49	49	32	28	29	31
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	83	82	81	80	79	78	77	76	75	73	73	72
Retained Earnings Accumulated Deficit	-75	-75	-75	-74	-43	-41	-38	-36	-33	-30	-28	-28
Stockholders Equity	8	7	6	6	35	37	39	39	42	43	45	44
Minority Interest	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Liabilities And Stockholders Equity	69	69	73	71	99	96	88	89	73	71	74	75
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Common Stock Shares Issued	9	9	9	9	9	9	9	9	9	9	9	9
Shares Outstanding	9	9	9	9	9	9	9	9	9	9	9	9

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	9.78%	21.53%	66.63%	-	-	-	-	-	-	-	-	-
2025	-5.78%	-5.27%	-22.81%	5.17%	-2.29%	-8.21%	2.75%	9.43%	4.22%	14.88%	16.48%	15.10%
2024	2.66%	-8.27%	-1.98%	20.01%	5.53%	20.41%	5.90%	-3.18%	5.00%	-5.67%	0.96%	-7.66%
2023	-	-	-	-20.01%	-31.07%	-39.46%	24.47%	40.29%	20.06%	-6.79%	-15.83%	-17.02%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.58	2.28	1.80	1.80	2.26	2.77	2.18	2.23	1.80	1.35	1.38	1.46
Quick Ratio	2.24	1.99	1.54	1.56	1.95	2.45	1.93	1.99	1.45	0.95	0.99	1.04
Working Capital	19.71M	17.50M	14.92M	13.87M	18.79M	23.56M	18.02M	17.57M	9.25M	4.44M	5.24M	6.15M
Leverage & Debt
Debt to Equity	7.71	8.86	11.30	10.56	1.79	1.63	1.26	1.24	0.77	0.64	0.66	0.71
Interest Coverage TTM	1.24	1.26	1.08	2.77	2.10	0.87	0.40	-3.18	-4.95	-6.10	-8.86	-16.67
Debt Ratio	0.89	0.90	0.92	0.91	0.64	0.62	0.56	0.55	0.44	0.39	0.40	0.42
Efficiency & Turnover
Asset Turnover TTM	1.31	1.30	1.28	1.28	1.13	1.09	1.07	0.96	0.98	1.04	0.96	0.93
Days Sales Outstanding TTM	41.79	46.24	-	-	-	-	-	-	-	-	-	-
Receivables Turnover TTM	8.73	7.89	-	-	-	-	-	-	-	-	-	-
Per Share Metrics
Diluted EPS TTM	-3.70	-3.74	-4.36	-4.19	-1.11	-1.33	-1.14	-0.98	-0.77	-0.58	-0.52	-0.53
Free Cash Flow Per Share TTM	0.52	0.39	0.25	-0.10	0.01	-0.27	-0.03	-0.23	-0.37	-0.40	-0.42	-0.40
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	93.03%	92.92%	92.71%	92.25%	91.76%	91.17%	90.61%	90.16%	89.73%	88.80%	87.92%	86.53%
Operating Profit Margin TTM	7.67%	8.49%	7.08%	10.95%	9.25%	3.95%	1.45%	-4.95%	-7.66%	-6.66%	-6.49%	-11.36%
Net Profit Margin TTM	-29.15%	-31.24%	-36.43%	-36.76%	-10.20%	-12.48%	-11.15%	-10.68%	-9.00%	-7.13%	-6.62%	-7.01%
Growth Metrics
Net Revenue Growth (1Y)	12.96%	17.38%	18.97%	30.52%	34.26%	34.65%	33.36%	24.66%	21.42%	26.98%	41.77%	66.71%
Net Income Growth (1Y)	222.79%	193.81%	288.66%	349.17%	52.24%	135.57%	124.59%	89.90%	35.71%	-21.50%	-46.82%	-61.62%
EPS Growth (1Y)	220.94%	189.20%	282.41%	342.45%	49.69%	131.43%	119.16%	85.78%	31.82%	-23.79%	-49.21%	-62.66%
Valuation Metrics
P/E TTM	-6.38	-4.45	-5.36	-7.33	-24.66	-23.15	-29.15	-30.90	-36.69	-64.22	-79.07	-59.09
P/B TTM	25.73	21.28	33.96	44.62	6.91	7.21	7.24	6.53	5.73	7.20	7.63	5.85
P/S TTM	1.86	1.39	1.95	2.69	2.52	2.89	3.25	3.30	3.30	4.58	5.24	4.14
Market Cap	204.35M	149.58M	201.35M	274.36M	244.52M	264.56M	281.68M	257.57M	238.99M	311.52M	340.26M	259.39M
Enterprise Value	235.41M	182.21M	230.74M	304.51M	271.78M	287.27M	296.49M	271.37M	247.21M	318.39M	344.81M	262.84M
Calculated Values
Free Cash Flow TTM	4.50M	3.37M	2.16M	-842.05K	82.37K	-2.29M	-229.63K	-1.99M	-3.14M	-3.40M	-3.51M	-3.31M
Net Debt	31.06M	32.63M	29.39M	30.15M	27.26M	22.71M	14.81M	13.80M	8.22M	6.87M	4.55M	3.45M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2022-11-08Sale

Owner: Fleming, Zachary B.

Title: Chief Executive Officer

Shares: 417

Price/Share: $33.00

Value: $13,761.00

Shares Owned: 36,270

Relationship: Officer

Ownership: Direct

2022-11-04Sale

Owner: Fleming, Zachary B.

Title: Chief Executive Officer

Shares: 563

Price/Share: $33.00

Value: $18,579.00

Shares Owned: 36,687

Relationship: Officer

Ownership: Direct

2022-11-02Sale

Owner: Fleming, Zachary B.

Title: Chief Executive Officer

Shares: 20

Price/Share: $33.02

Value: $660.40

Shares Owned: 37,250

Relationship: Officer

Ownership: Direct

2022-09-22Sale

Owner: Bowman, Shawn M.

Title: Pres. - Strategic Partnerships

Shares: 1,000

Price/Share: $28.05

Value: $28,050.00

Shares Owned: 18,550

Relationship: Officer

Ownership: Direct

2022-07-06Sale

Owner: Fleming, Zachary B.

Title: Chief Executive Officer

Shares: 1,415

Price/Share: $22.50

Value: $31,837.50

Shares Owned: 37,270

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2022-11-08	Fleming, Zachary B.	Officer	Chief Executive Officer	Direct	Sale	417	33.00	$13,761.00	36,270	4
2022-11-04	Fleming, Zachary B.	Officer	Chief Executive Officer	Direct	Sale	563	33.00	$18,579.00	36,687	4
2022-11-02	Fleming, Zachary B.	Officer	Chief Executive Officer	Direct	Sale	20	33.02	$660.40	37,250	4
2022-09-22	Bowman, Shawn M.	Officer	Pres. - Strategic Partnerships	Direct	Sale	1,000	28.05	$28,050.00	18,550	4
2022-07-06	Fleming, Zachary B.	Officer	Chief Executive Officer	Direct	Sale	1,415	22.50	$31,837.50	37,270	4
2022-06-29	Fleming, Zachary B.	Officer	Chief Executive Officer	Direct	Sale	294	21.00	$6,174.00	38,950	4
2022-06-24	Fleming, Zachary B.	Officer	Chief Executive Officer	Direct	Sale	457	21.00	$9,597.00	39,313	4
2022-06-17	Bowman, Shawn M.	Officer	Pres. - Strategic Partnerships	Direct	Sale	1,000	20.02	$20,020.00	19,550	4
2021-10-26	Fleming, Zachary B.	Officer	President - Surgical Div.	Direct	Sale	1,000	34.04	$34,040.00	17,708	4
2021-10-20	Bowman, Shawn M.	Officer	President - Wound Care Div.	Direct	Sale	1,000	33.98	$33,980.00	15,668	4
2021-10-05	Fleming, Zachary B.	Officer	President - Surgical Div.	Direct	Sale	1,000	33.08	$33,080.00	18,708	4
2021-09-28	Bowman, Shawn M.	Officer	President - Wound Care Div.	Direct	Sale	1,000	33.33	$33,330.00	16,668	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

16.74%

Inst. Shares: 1,457,486

Shares Outstanding: 8,706,678

2025-12-31

111.59%

Inst. Shares: 9,622,368

Shares Outstanding: 8,623,028

2025-09-30

105.19%

Inst. Shares: 9,095,360

Shares Outstanding: 8,646,668

2025-06-30

112.32%

Inst. Shares: 9,674,226

Shares Outstanding: 8,612,986

2025-03-31

76.18%

Inst. Shares: 6,529,041

Shares Outstanding: 8,570,104

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,457,486	8,706,678	16.74%
2025-12-31	9,622,368	8,623,028	111.59%
2025-09-30	9,095,360	8,646,668	105.19%
2025-06-30	9,674,226	8,612,986	112.32%
2025-03-31	6,529,041	8,570,104	76.18%
2024-12-31	911,254	8,484,224	10.74%
2024-09-30	761,669	8,517,381	8.94%
2024-06-30	665,729	8,468,835	7.86%
2024-03-31	635,036	8,419,528	7.54%
2023-12-31	641,683	8,278,949	7.75%
2023-09-30	600,089	8,332,341	7.20%
2023-06-30	639,733	8,226,271	7.78%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Sanara MedTech Inc. (SMTI) — SEC Financial Statements & Analysis

Sanara MedTech Inc. (SMTI) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in TX. Sanara MedTech Inc. trades on Nasdaq as: SMTI. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Sanara MedTech Inc. reported a 12.96% year-over-year revenue growth, a Gross Profit Margin of 93.03% (TTM), a Debt-to-Equity ratio of 7.71x, a Price-to-Sales (P/S) ratio of 1.86x (TTM), a Price-to-Book (P/B) ratio of 25.73x (TTM), at a market cap of $204.35M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 12.96%
Gross Profit Margin TTM: 93.03%
Debt To Equity: 7.71x
P/S TTM: 1.86x
P/B TTM: 25.73x
Market Cap: $204.35M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sanara MedTech Inc. in?

Sanara MedTech Inc. (SMTI) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.

What is SMTI's market cap?

Sanara MedTech Inc. (SMTI) has a market capitalization of $204.35M as of 2026-06-30.

What exchange does SMTI trade on?

Sanara MedTech Inc. (SMTI) trades on the Nasdaq.

Where is Sanara MedTech Inc. incorporated?

Sanara MedTech Inc. is incorporated in TX.